Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation. | Mol Oncol | 2026 | 42808303 | PubTator, text mining | PubMed |
| A De Novo 16p13.3 Triplication Underlying Early-Onset Complex Neurodegeneration. | Mov Disord | 2026 | 42734088 | PubTator, text mining | PubMed |
| PDK1 signaling in cancer: Current status and future perspectives. | Int J Biol Macromol | 2026 | 42716156 | PubTator, text mining | PubMed |
| Osthole and matrine suppress malignant progression of lead-exposed NSCLC via regulating cellular homeostasis: A combined network pharmacology and in vitro experimental study. | Phytomedicine | 2026 | 42555991 | PubTator, text mining | PubMed |
| The PDPK1-RSK2 axis as a potential convergent therapeutic vulnerability in B-cell lymphomas. | Expert Opin Ther Targets | 2026 | 42489440 | PubTator, text mining | PubMed |
| Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen. | Anticancer Drugs | 2026 | 42390376 | PubTator, text mining | PubMed |
| Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs. | Cell Death Dis | 2026 | 42259783 | PubTator, text mining | PubMed |
| Penfluridol directly targets PDPK1 to suppress AKT1 phosphorylation and stabilize CTR1, inducing cuproptosis in colorectal cancer. | Acta Pharmacol Sin | 2026 | 42185682 | PubTator, text mining | PubMed |
| Thr308-dephosphorylated AKT1 licenses SQSTM1-LC3C-mediated antiviral autophagy. | Autophagy | 2026 | 42152503 | PubTator, text mining | PubMed |
| Genomic profile of an IDH-wild-type glioblastoma diagnosed following TNF-α inhibitor therapy: a molecular case study. | Front Oncol | 2026 | 42130630 | PubTator, text mining | PubMed |
| [The roles and regulatory mechanisms of serum and glucocorticoid-regulated kinase 1 in miscarriage and preeclampsia]. | Sheng Li Xue Bao | 2026 | 42014335 | PubTator, text mining | PubMed |
| Phosphoinositide-dependent kinase 1 (PDK1) in cancer: molecular insights and therapeutic strategies. | Front Chem | 2026 | 41928774 | PubTator, text mining | PubMed |
| Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-loss. | Cell Rep Methods | 2026 | 41916299 | PubTator, text mining | PubMed |
| Short and Long Non-Coding RNAs in Renal Cell Carcinoma. | Noncoding RNA | 2026 | 41874142 | PubTator, text mining | PubMed |
| PDPK1 activates BIRC3 via NFKB1 to promote radiotherapy resistance in lung adenocarcinoma. | Cancer Cell Int | 2026 | 41862915 | PubTator, text mining | PubMed |
| Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome. | NPJ Genom Med | 2026 | 41844650 | PubTator, text mining | PubMed |
| Cellular signaling pathway of Shiga toxin-induced ATP release. | Front Cell Infect Microbiol | 2026 | 41809984 | PubTator, text mining | PubMed |
| FBXW7 Targets the SPT6-ΔNp63 Axis for Degradation to Inhibit Esophageal Tumorigenesis Induced by 4-Nitroquinoline N-Oxide. | MedComm (2020) | 2026 | 41799933 | PubTator, text mining | PubMed |
| Dynamic dual regulation of amphiregulin in liver pathophysiology: balancing regeneration and disease progression via the EGFR axis. | Front Med (Lausanne) | 2026 | 41788718 | PubTator, text mining | PubMed |
| The structure and function of membrane protein in coronavirus infection and its applications in the development of vaccines and therapeutic drugs. | Front Microbiol | 2026 | 41788334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers